The solution may be to slow the titration schedule, extending the time at each dose level from four weeks to six or eight weeks
Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knofel MT, et al
The FDA has issued more than 50 warning letters to companies selling questionable GLP-1 products
Liraglutide attenuates nonalcoholic fatty liver disease by modulating gut microbiota in rats administered a high-fat diet
Tissue-Level Interpretation Changes in body weight or adipose mass can result from altered food intake, hydration, lean mass, lipid synthesis, lipid mobilization, substrate oxidation, activity, thermogenesis, gastrointestinal effects, or tissue-specific adaptation